Cargando…

Persistent inflammation worsens short-term outcomes in massive stroke patients

BACKGROUND: Persistent inflammation is an important driver of disease progression and affects prognosis. Some indicators of inflammation predict short-term outcomes. The relationship between prognosis, especially mortality, and persistent inflammation in massive stroke has not been studied, and this...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Duanlu, Wang, Chunjie, Ye, Xiaofei, Zhong, Ping, Wu, Danhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874622/
https://www.ncbi.nlm.nih.gov/pubmed/33568099
http://dx.doi.org/10.1186/s12883-021-02097-9
_version_ 1783649621750317056
author Hou, Duanlu
Wang, Chunjie
Ye, Xiaofei
Zhong, Ping
Wu, Danhong
author_facet Hou, Duanlu
Wang, Chunjie
Ye, Xiaofei
Zhong, Ping
Wu, Danhong
author_sort Hou, Duanlu
collection PubMed
description BACKGROUND: Persistent inflammation is an important driver of disease progression and affects prognosis. Some indicators of inflammation predict short-term outcomes. The relationship between prognosis, especially mortality, and persistent inflammation in massive stroke has not been studied, and this has been the subject of our research. METHODS: From April 1, 2017 to February 1, 2020, consecutive patients were prospectively enrolled. Clinical data, laboratory data, imaging data and follow-up infections morbidity were compared between 2 groups according to modified Rankin scale (mRS) scores (mRS < 3 and ≥ 3) at 1 month. The binomial logistic analysis was used to determine independent factors of 1-month prognosis. Short-term functional outcome, mortality and infection rates in massive stroke with and without persistent inflammation were compared. RESULTS: One hundred thirty-nine patients with massive stroke were included from 800 patients. We found that admission blood glucose levels (p = 0.005), proportions of cerebral hemispheric (p = 0.001), posterior circulatory (p = 0.035), and lacunar (p = 0.022) ischemia were higher in poor outcome patients; neutrophil-to-lymphocyte ratio (odd ratio = 1.87, 95%CI 1.14–3.07, p = 0.013) and blood glucose concentrations (odd ratio = 1.34, 95%CI 1.01–1.79, p = 0.043) can independently predict the short-term prognosis in massive stroke patients. We also found that the incidence of pulmonary infection (p = 0.009), one-month mortality (p = 0.003) and adverse outcomes (p = 0.0005) were higher in patients with persistent inflammation. CONCLUSIONS: This study suggested that persistent inflammation is associated with poor prognosis, 1-month mortality and the occurrence of in-hospital pulmonary infection and that higher baseline inflammation level predicts short-term poor outcomes in massive stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-021-02097-9.
format Online
Article
Text
id pubmed-7874622
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78746222021-02-11 Persistent inflammation worsens short-term outcomes in massive stroke patients Hou, Duanlu Wang, Chunjie Ye, Xiaofei Zhong, Ping Wu, Danhong BMC Neurol Research Article BACKGROUND: Persistent inflammation is an important driver of disease progression and affects prognosis. Some indicators of inflammation predict short-term outcomes. The relationship between prognosis, especially mortality, and persistent inflammation in massive stroke has not been studied, and this has been the subject of our research. METHODS: From April 1, 2017 to February 1, 2020, consecutive patients were prospectively enrolled. Clinical data, laboratory data, imaging data and follow-up infections morbidity were compared between 2 groups according to modified Rankin scale (mRS) scores (mRS < 3 and ≥ 3) at 1 month. The binomial logistic analysis was used to determine independent factors of 1-month prognosis. Short-term functional outcome, mortality and infection rates in massive stroke with and without persistent inflammation were compared. RESULTS: One hundred thirty-nine patients with massive stroke were included from 800 patients. We found that admission blood glucose levels (p = 0.005), proportions of cerebral hemispheric (p = 0.001), posterior circulatory (p = 0.035), and lacunar (p = 0.022) ischemia were higher in poor outcome patients; neutrophil-to-lymphocyte ratio (odd ratio = 1.87, 95%CI 1.14–3.07, p = 0.013) and blood glucose concentrations (odd ratio = 1.34, 95%CI 1.01–1.79, p = 0.043) can independently predict the short-term prognosis in massive stroke patients. We also found that the incidence of pulmonary infection (p = 0.009), one-month mortality (p = 0.003) and adverse outcomes (p = 0.0005) were higher in patients with persistent inflammation. CONCLUSIONS: This study suggested that persistent inflammation is associated with poor prognosis, 1-month mortality and the occurrence of in-hospital pulmonary infection and that higher baseline inflammation level predicts short-term poor outcomes in massive stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-021-02097-9. BioMed Central 2021-02-10 /pmc/articles/PMC7874622/ /pubmed/33568099 http://dx.doi.org/10.1186/s12883-021-02097-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Hou, Duanlu
Wang, Chunjie
Ye, Xiaofei
Zhong, Ping
Wu, Danhong
Persistent inflammation worsens short-term outcomes in massive stroke patients
title Persistent inflammation worsens short-term outcomes in massive stroke patients
title_full Persistent inflammation worsens short-term outcomes in massive stroke patients
title_fullStr Persistent inflammation worsens short-term outcomes in massive stroke patients
title_full_unstemmed Persistent inflammation worsens short-term outcomes in massive stroke patients
title_short Persistent inflammation worsens short-term outcomes in massive stroke patients
title_sort persistent inflammation worsens short-term outcomes in massive stroke patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874622/
https://www.ncbi.nlm.nih.gov/pubmed/33568099
http://dx.doi.org/10.1186/s12883-021-02097-9
work_keys_str_mv AT houduanlu persistentinflammationworsensshorttermoutcomesinmassivestrokepatients
AT wangchunjie persistentinflammationworsensshorttermoutcomesinmassivestrokepatients
AT yexiaofei persistentinflammationworsensshorttermoutcomesinmassivestrokepatients
AT zhongping persistentinflammationworsensshorttermoutcomesinmassivestrokepatients
AT wudanhong persistentinflammationworsensshorttermoutcomesinmassivestrokepatients